Practice question

Answer the question and get instant feedback.

ModerateCardiologyHFrEFus-abfmus-abimus-usmle-step-3

A 58-year-old with HFrEF (EF 28%) on ARNI, beta-blocker, SGLT2 inhibitor remains symptomatic. Next mortality-reducing agent?

Educational content. Not a substitute for clinical judgement or local policy.